Bausch Historical Cash Flow
| BHC Stock | USD 8.37 0.25 3.08% |
Analysis of Bausch Health cash flow over time is an excellent tool to project Bausch Health Companies future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Free Cash Flow of 566.3 M or Begin Period Cash Flow of 569 M as it is a great indicator of Bausch Health ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Bausch Health Companies latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Bausch Health Companies is a good buy for the upcoming year.
Bausch |
About Bausch Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Bausch balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Bausch's non-liquid assets can be easily converted into cash.
Bausch Health Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Bausch Health Companies to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Bausch Health operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Bausch Health Companies financial statement analysis. It represents the amount of money remaining after all of Bausch Health Companies operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most accounts from Bausch Health's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Bausch Health Companies current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. At present, Bausch Health's Total Cash From Financing Activities is projected to decrease significantly based on the last few years of reporting. The current year's Cash Flows Other Operating is expected to grow to about 975.7 M, whereas Sale Purchase Of Stock is forecasted to decline to (25.2 M).
Bausch Health cash flow statement Correlations
Click cells to compare fundamentals
Bausch Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Bausch Health cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Sale Purchase Of Stock | (40M) | (30M) | (52M) | (31M) | (24M) | (25.2M) | |
| Change To Inventory | (209M) | (77M) | (16M) | (198M) | (322M) | (305.9M) | |
| Change In Cash | 2.5B | (1.4B) | 303M | (1.5B) | 371M | 389.6M | |
| Free Cash Flow | 1.2B | 802M | 1.1B | (996M) | 760M | 566.3M | |
| Change In Working Capital | (318M) | (366M) | (128M) | (396M) | (582M) | (552.9M) | |
| Begin Period Cash Flow | 723M | 3.2B | 1.8B | 2.1B | 591M | 569.0M | |
| Other Cashflows From Financing Activities | 5.9B | (107M) | (173M) | (139M) | (106M) | (100.7M) | |
| Depreciation | 2.1B | 1.8B | 1.6B | 1.4B | 1.3B | 926.7M | |
| Other Non Cash Items | 1.7B | 581M | 1.0B | (1.5B) | 778M | 406.5M | |
| Capital Expenditures | 278M | 309M | 283M | 268M | 272M | 170.4M | |
| Net Income | (1.8B) | (559M) | (937M) | (212M) | (611M) | (580.5M) | |
| Total Cash From Financing Activities | 1.4B | (2.3B) | (1.5B) | (474M) | 1.5B | 1.5B | |
| End Period Cash Flow | 3.2B | 1.8B | 2.1B | 591M | 962M | 604.5M | |
| Change To Netincome | 1.4B | (376M) | (189M) | (2.5B) | (2.2B) | (2.1B) | |
| Change To Account Receivables | 39M | 170M | (229M) | (57M) | (195M) | (185.3M) | |
| Change To Liabilities | (149M) | (471M) | 121M | (75M) | (67.5M) | (64.1M) | |
| Other Cashflows From Investing Activities | (143M) | 37M | 682M | (35M) | (40.3M) | (42.3M) | |
| Total Cashflows From Investing Activities | (419M) | (261M) | 409M | (303M) | (348.5M) | (365.9M) | |
| Stock Based Compensation | 102M | 105M | 128M | 126M | 132M | 100.0M | |
| Investments | (6M) | 4M | (4M) | 5M | (2.1B) | (2.0B) | |
| Change Receivables | 39M | 170M | (229M) | (57M) | (65.6M) | (68.8M) | |
| Net Borrowings | 1.5B | (2.2B) | (1.4B) | (1.1B) | (972.9M) | (924.3M) | |
| Cash And Cash Equivalents Changes | 2.5B | (1.4B) | 322M | (1.5B) | (1.4B) | (1.3B) | |
| Cash Flows Other Operating | 78M | 538M | 1.1B | 808M | 929.2M | 975.7M | |
| Change To Operating Activities | 1M | 12M | (4M) | (66M) | (59.4M) | (56.4M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Bausch Health Companies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bausch Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bausch Health Companies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bausch Health Companies Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bausch Health. If investors know Bausch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bausch Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.61) | Earnings Share (0.48) | Revenue Per Share 25.794 | Quarterly Revenue Growth 0.122 | Return On Assets 0.0415 |
The market value of Bausch Health Companies is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Health's value that differs from its market value or its book value, called intrinsic value, which is Bausch Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bausch Health's market value can be influenced by many factors that don't directly affect Bausch Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bausch Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.